TACSTD2 and thyroid cancer: In summary, we show that Trop2 is overexpressed in thyroid cancer and promotes the invasion and migration of thyroid cancer cells via MAPK ERK/JNK/AP1/MMP2 signaling, potentially offering new molecular targets for treatment of thyroid cancer.